facebook tracking pixel
Dr.ª Shilan Aslani

Dr.ª Shilan Aslani

Fundadora e Gerente

Diretora da clínica

Percurso Académico

  • Doutoramento em Neurociências, pela Universidade do Minho, Portugal (2014).
  • Mestrado em Medicina Molecular pelo Imperial College London, Londres, Reino Unido (2011).
  • Licenciatura em Biologia Molecular pela Universidade Azad, Irão.(2009).

Percurso Profissional

  • Fundadora e gerente: NeuroImprove Clinic, Porto (2015 - Presente).
  • Formadora: NeuroImprove Academy (2020 - Presente).
  • Investigadora: Hospital de Hammersmith, Imperial College London, Londres, Reino Unido (2010 - 2011).
  • Investigadora: Diabetes and bio-nanotechnology units in Endocrinology & Metabolism Research Institute (EMRI), Teerã, Irão (2008 - 2010).
  • Assistente médica e Diretora Técnica: White Complex laser clinic, Teerã, Irão (2002 - 2003).

Outras Certificações

  • Curso de formação inicial de formadores, pela Joviform (2020).
  • BCIA neurofeedback certification, BFE (Biofeedback Federation of Europe) 19th workshop, pela BCIA (2017).
  • Curso “Neurofeedback- 36 BCIA Didactic Hours”, pela New Mind Academy (2016).
  • Curso “Introductory course in Neurofeedback”, pelo Euibion (2015).
  • Curso “Fundamentals in neuroscience” Instituto de Investigação em Ciência da Vida e da Saúde (ICVS) pelo Universidade do Minho (2013).
  • Laboratory animal science, pelo ICVS, Universidade do Minho (2013).
  • Curso “Biostatistics in Health Sciences” pelo ICVS, Universidade do Minho (2012).

Publicações

  • J. Castelhano-Carlos, S. Aslani, N. Sousa (2020) The Impact of Physical Enrichment in the Structure of the Medial Prefrontal Cortex and Nucleus Accumbens of the Adult Male Rat Brain. Neuroscience. 454: (51-60).
  • Morais, J. Pereira, S. Aslani, et al, Joao M Besa (2016) The impact of antipsychotic drugs on behaviour: new perspectives from the methylazoxymethanol rodent model of schizophrenia. European Neuropsychopharmacology 26(2): S450-S451.
  • Aslani, N. Vieira, F. Marques, P.S. Costa, N. Sousa, J.A. Palha. (2015) The effect of obesity-inducing high fat diet on rat’s mood and feeding behavior and response to stress. Translational Psychiatry. 5 (684).
  • Aslani, M.R. Harb, P.S. Costa, O.F.X. Almeida, N. Sousa, J.A. Palha. (2013) Day and night: The diurnal phase influences the response to chronic mild stress. Frontiers in Behavioral Neuroscience. 8 (82): 1-8.
  • Mirzaei, A. Hossein-nezhad, S. Aslani, S. Emamgholipour, M. Karimi, S.A. Keshavarz. (2012). Energy Expenditure Regulation via Macrophage Migration Inhibitory Factor (MIF) in Obesity and In Vitro Anti-MIF Effect of Alpinia Officinarum Hance Extraction. Endocrine practice. 18(1): 30-48, PMID: 21803717.
  • Aslani, A. Hossein-nezhad, Z. Maghbooli, K. Mirzae, F. Karimi. (2011) Genetic variation in Macrophage migration inhibitory factor associated with Gestational Diabetes Mellitus and metabolic syndrome. Horm Metab Res. 43(8): 557- 561, PMID: 21512965.
  • Aslani, A. Hossein-nezhad, K. Mirzae, Z. Maghbooli, A.N. Afshar, F. Karimi. (2011). VDR FokI polymorphism and its potential role in the pathogenesis of Gestational Diabetes Mellitus and its complications. Gynecological Endocrinology, 27(12):1055-60, PMID: 21663527.
  • Aslani, A. Hossein-nezhad, K. Mirzae, Z. Maghbooli, S.N. Asgarabad, F. Karimi. (2011) Tandem repeats of the CATT element of macrophage migration inhibitory factor gene may predict GDM severity. European Journal of Inflammation, 9(2): 185-191.
  • Hossein-nezhad, K. Mirzaei, S. Aslani, A. Tootee, F. Karimi. (2011) MIF expression in induced peripheral blood mononuclear cells by vitamin D3 and its potential correlation with resting metabolic rate in obesity. European Journal of Inflammation. 9(2): 125-134.

Agende agora a sua consulta

Ou se preferir, preencha o formulário em baixo e nós entraremos em contacto consigo.
Obrigado pelo seu pedido de marcação de consulta. Entraremos em contacto
Ups! Alguma coisa correu mal a submeter o formulário, por favor tente de novo.